Document Preview Unavailable

Dipeptidyl peptidase‐4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes

Abe, Takahiro; Matsubayashi, Yasuhiro; Muragishi, Sayaka; Yoshida, Akihiro; Suganami, Hideki; et al.  Journal of Diabetes Investigation Vol. 12, Iss. 10,  (Oct 2021): 1805-1815.

You might have access to this document